27th - 29th April 2026, Liverpool, UK
In April 2026, BHIVA and BASHH will be joining each other for the sixth joint BHIVA BASHH conference.
The Joint BASHH/BHIVA guidelines for the sexual & reproductive health of people living with HIV 2025 are now available for consultation until Friday 27th February 2026.
Cosmetic treatments are procedures designed to change an individual’s appearance. Treatments may be surgical or non-surgical, and can involve chemicals, needles or laser. Read BHIVA's guidance.
The overall purpose of these guidelines is to provide guidance on best clinical practice for antiretroviral therapy (ART) and management of adults living with human immunodeficiency virus (HIV).
Learn more about the British HIV Association (BHIVA).
BHIVA produces clinical guidelines for the management of HIV which, while primarily intended for the use of UK clinicians, have international influence.
The BHIVA Education Working Group prepare questions based on various BHIVA guidelines. Module development is ongoing to keep up to date with new guidelines.
There are many benefits to becoming a BHIVA member including discounted registration for BHIVA conferences (CPD approved), free subscription to the BHIVA journal HIV Medicine, access to CPD Certificates on successful completion of e-learning modules and much more!
HIV Medicine is the official journal of the British HIV Association (BHIVA), the European AIDS Clinical Society (EACS) and Deutsche AIDS-Gesellschaft e.V. (DAIG), and is published by Wiley. HIV Medicine is a peer-reviewed journal publishing original articles, reviews and guidelines on all aspects of HIV treatment and diagnosis. The journal is specifically aimed at researchers and clinicians with responsibility for treating people living with HIV.
